Related Experiment Video
Updated: Apr 1, 2026

Characterization of a Pathogenic Escherichia coli Strain Derived from Oreochromis spp. Farms Using Whole-Genome Sequencing
Published on: December 23, 2022
Complete Genome Sequence of Enterotoxigenic Escherichia coli Myophage Murica
Joseph N Wilder1, Jacob C Lancaster1, Jesse L Cahill1
1Center for Phage Technology, Texas A&M University, College Station, Texas, USA.
Abstract:
Murica is an rv5-like myophage that infects enterotoxigenic Escherichia coli. Pathogenic E. coli strains are responsible for many intestinal diseases, and phages that infect these bacteria may prove useful in preventing severe health issues. The following is a report of the complete genome sequence of Murica and its important features.
Insights
Researchers sequenced the genome of Murica, a bacteriophage targeting enterotoxigenic Escherichia coli. This phage shows potential for combating E. coli-related intestinal diseases.
Area of Science:
- Microbiology
- Virology
- Genomics
Background:
- Enterotoxigenic Escherichia coli (E. coli) causes significant intestinal diseases.
- Bacteriophages (phages) are viruses that infect bacteria and are being explored as therapeutic agents.
- Phage therapy offers a potential alternative or supplement to antibiotics for bacterial infections.
Purpose of the Study:
- To report the complete genome sequence of Murica, an rv5-like myophage.
- To identify important genomic features of Murica.
- To assess the potential of Murica for therapeutic applications against pathogenic E. coli.
Main Methods:
- Whole genome sequencing of the Murica bacteriophage.
- Bioinformatic analysis of the Murica genome.
- Comparative genomics to identify related phages and features.
Main Results:
- The complete genome sequence of Murica was determined.
- Key genomic features and characteristics of Murica were identified.
- Murica was confirmed as an rv5-like myophage infecting E. coli.
Conclusions:
- The genomic data provides a foundation for understanding Murica's biology and replication.
- Murica represents a potential candidate for phage therapy against enterotoxigenic E. coli.
- Further research into Murica's efficacy and safety is warranted.
Related Concept Videos
DNA Bacteriophages
Bacterial Gastroenteritis
Viral Replication: Lytic Cycle

